z-logo
open-access-imgOpen Access
Preliminary study on Anti-inflammatory and Anti-tumor Effects of Gelatin - based on pH-responsive Drug-loaded Nanoparticles
Author(s) -
F.C. Lin
Publication year - 2019
Publication title -
proceedings of anticancer research
Language(s) - English
Resource type - Journals
eISSN - 2208-3553
pISSN - 2208-3545
DOI - 10.26689/par.v3i2.984
Subject(s) - gelatin , ethylene glycol , doxorubicin , aspirin , drug , chemistry , pharmacology , toxicity , chemotherapy , medicine , biochemistry , surgery , organic chemistry
 Gelatin as one kind of nano-drug carrier is a polysaccharide which can be absorbed after releasing all nano-drugs. Poly(ethylene glycol) as a polymer material that can modify nano-drugs is able to extend circulatory time of doxorubicin and aspirin, enhance stability and reduce toxicity. At precancerous, aspirin will be released slowly to resist inflammation. When tumor cell appears at a more advance stage, doxorubicin release from Gel to achieve anti-tumor effect. After all those steps, poly (ethylene glycol) could be expelled from body. In brief, the nano-drug that has doxorubicin and aspirin is able to prevent the growth of tumor cells and kill them when they appear more precisely.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here